Business Context and Reporting Period
This Form 8-K, dated May 30, 2025, reports on events occurring between May 27 and May 28, 2025, for BioSig Technologies, Inc. (BSGM). The filing details the consummation of a Share Purchase Agreement to acquire Streamex Exchange Corporation, a blockchain infrastructure company. The transaction involved a reverse merger structure where BioSig subsidiaries issued exchangeable shares to Streamex shareholders.
Key Financial Metrics and Transaction Terms
- Acquisition Consideration: BioSig subsidiaries issued an aggregate of 109,070,056.6977 Exchangeable Shares to Streamex shareholders.
- Exchange Ratio: The ratio was adjusted to 2.046862 Exchangeable Shares for each Streamex share held (revised from an initial 2.05).
- Finder Fees: The Company agreed to issue common stock representing 3.75% of its outstanding shares immediately prior to closing to three finders as compensation for introductions.
- Executive Compensation: Outgoing CEO Anthony Amato received a severance package of $400,000 payable over eight months, plus full acceleration of outstanding equity awards.
- Financial Statements: No revenue, profit, cash flow, or debt metrics are provided in this filing. Required financial statements and pro forma information are to be filed within 71 days.
Material Changes Versus Prior Period
The primary material change is the completion of the acquisition of Streamex on May 28, 2025. This transaction fundamentally alters the Company's capital structure through the issuance of significant equity and changes the corporate leadership and board composition. The filing does not provide comparative financial performance data against prior periods.
Guidance, Outlook, and Management Commentary
- Leadership Transition: Anthony Amato resigned as CEO, President, and Chairman. Henry McPhie (former Streamex CEO) was appointed CEO, and Morgan Lekstrom (former Streamex Chairman) was appointed Chairman of the Board.
- Board Composition: The Board now consists of six directors: four designated by BioSig (including Mr. Amato) and two designated by Streamex (Mr. McPhie and Mr. Lekstrom).
- Strategic Outlook: Management commentary highlights a strategic expansion into decentralized technologies and blockchain infrastructure, leveraging the new leadership's experience in Web3 and commodities.
- Risks and Contingencies: The filing notes that financial statements for the acquired business are not yet filed. The issuance of finder shares is contingent upon shareholder approval of certain matters.
Investor Verification Checklist
- Verify the exact number of shares outstanding post-closing to calculate the dilution impact of the 3.75% finder fee and the 109 million+ exchangeable shares.
- Monitor the upcoming filing (within 71 days) for the financial statements of Streamex to assess the acquired entity's revenue and debt profile.
- Confirm the status of shareholder approval for the "Parent Stockholder Matters" required to finalize the finder share issuance.
- Review the "Right to Place" agreement terms regarding Anthony Amato's 12-month lock-up on his securities.
- Check for the filing of the Special Voting Certificate of Designation to understand the rights attached to the new Special Voting Preferred Stock.